After Doc Uproar, NCCN Reverses Prostate Cancer Guidance : v

The cancer organization today largely reinstated its former advice that men with low-risk prostate cancer be offered active surveillance as the lone 'preferred' initial treatment option.

Related Keywords

New York , United States , Northwestern University , Illinois , Chicago , Matthew Cooperberg , Stacy Loeb , Edward Schaeffer , Lurie Comprehensive Cancer Center , Prostate Cancer Panel , Twitter , University Of California San Francisco , National Comprehensive Cancer Network , Medscape Medical News , Cancer Panel , Active Surveillance , California San Francisco , Prostate Carcinoma , Alignant Prostate Neoplasm , Prostate Cancer , Ancer Prostate , Cancer , Alignant Neoplasia , Arcinoma , Surveillance Of Prostate Cancer , Prostatic , Radiation Oncology , Prostate Specific Antigen Psa , Prostate Specific Antigen , Sa , Clinical Guidelines , Guidelines , Patient Safety , Surgery , Tissue , Professional Societies ,